John Temperato

John Temperato currently works at uMETHOD Health, Inc., as Chief Executive Officer from 2025, Naia Rare Diseases LLC, as Director from 2020, Salix Pharmaceuticals Ltd., as Senior Vice President-Sales & Managed Markets, and Academy of Managed Care Pharmacy, as Member.
Mr. Temperato also formerly worked at RDD Pharma Ltd., as Chief Executive Officer from 2019 to 2020, 9 Meters Biopharma, Inc., as President, Chief Executive Officer & Director from 2020 to 2023, Atlantic Healthcare Plc, as President & Chief Operating Officer, Melinta Subsidiary Corp., as President & Chief Operating Officer, and Melinta Therapeutics, Inc., as President & Chief Operating Officer.
Mr. Temperato received his undergraduate degree from the University of Bridgeport.